image
Healthcare - Biotechnology - NASDAQ - US
$ 4.33
0 %
$ 37.4 M
Market Cap
-1.01
P/E
INCOME STATEMENT
2.05 M REVENUE
34.67%
-36.6 M OPERATING INCOME
-14.28%
-34 M NET INCOME
-9.57%
EFFICIENCY
Earnings Waterfall Lumos Pharma, Inc.
image
Revenue 2.05 M
Cost Of Revenue 44 K
Gross Profit 2.01 M
Operating Expenses 38.7 M
Operating Income -36.6 M
Other Expenses -2.58 M
Net Income -34 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
REVENUE
Revenue 2.1 1.5 0.2 0.2 0.9 1.2 0.4 3.5 36.1 165.9 1.1 1.7 1.9 2.1 0.9 0.6
GROSS PROFIT
Cost Of Revenue 44 K 49 K 0 0 37 K (11.3) 1.4 0 (32.4) (6.6) 0 0 0 0 0 0
Gross Profit 2.0 1.5 0.2 0.2 0.9 12.5 (1.0) 3.5 68.5 172.6 1.1 1.7 1.9 2.1 0.9 0.6
OPERATING INCOME
Operating Expenses 38.7 33.6 31.6 26.5 46.1 63.6 73.3 94.3 69.7 48.4 31.1 23.3 19.9 18.7 10.8 10.0
Selling, General and Administrative Expenses 16.6 15.7 15.3 17.3 23.9 29.2 31.7 33.2 30.7 19.3 9.5 7.1 5.7 6.1 5.2 4.6
Research and Development Expenses 22.1 17.9 16.2 9.2 22.2 45.7 69.9 93.3 71.4 35.7 22.7 17.8 14.3 12.7 5.6 5.5
Operating Income (36.6) (32.0) (31.3) (26.3) (45.1) (62.4) (72.9) (90.8) (33.6) 117.6 (31.1) (23.3) (18.1) (16.7) (9.8) (9.4)
PRE-TAX INCOME
Interest Income Expense 0 0.9 0 0 50 K 52 K 0.1 22 K 0.1 26 K 33 K 38 K 42 K 47 K 9 K 2 K
Total Other Income 2.6 1.0 0.3 6.7 35.4 1.9 0.4 0.2 41 K 60 K 91 K 62 K 25 K 99 K 0.1 0.6
Pre-Tax Income (34.1) (31.1) (31.1) (19.6) (43.0) (60.6) (72.5) (90.5) (33.6) 117.6 (31.1) (23.3) (18.1) (16.6) (9.8) (9.4)
NET INCOME
Tax Provision 29 K 13 K (0.6) (14.0) 12 K (7.0) (0.6) (5.4) 6.7 14.8 0.1 (0.8) 41 K (0.4) (0.4) (0.3)
Net Income (34.0) (31.1) (30.4) (5.7) (43.0) (53.6) (72.0) (85.2) (40.4) 102.9 (31.2) (23.3) (18.1) (16.2) (9.4) (9.2)
EPS 4.18 3.71 3.65 0.84 297 13 20.7 26.4 12.7 31.1 11.1 10.1 26.8 10.2 5.91 5.74